Form 4 · LLY
Eli Lilly EVP Daniel Skovronsky reports a gift of 119 shares
Part of a grouped insider digest: see all related filings with totals →
Daniel Skovronsky, Eli Lilly's EVP, CS&PO & Pres. LRL, filed a Form 4 on Nov 3, 2026 at 4:15 PM ET reporting transactions on Nov 2, 2026.
The filing reports 119 shares given as a gift (code G).
After these transactions, the filing lists about 159,953 shares held directly.
Effect on holdings
Taken together, the rows reported here lowered Daniel Skovronsky's directly held shares by 0.1%, from about 160,072 to about 159,953.
Reporting person
- Daniel Skovronsky, EVP, CS&PO & Pres. LRL (as filed: Skovronsky Daniel)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | G | Common Stock | 119 | Disposed | 159,953 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 3, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Eli Lilly company file → · More Eli Lilly filings
Disclosures
- Editor holdings in LLY
- The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
- Last updated
- Nov 3, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.